• 首页期刊简介编委会刊物订阅专栏专刊电子刊广告合作联系我们English
引用本文:田雪珂,张绮雯,贾萌萌,杨晶,张晓坚.儿童患者伏立康唑治疗药物监测研究进展[J].中国现代应用药学,2021,38(12):1529-1536.
TIAN Xueke,ZHANG Qiwen,JIA Mengmeng,YANG Jing,ZHANG Xiaojian.Research Progress of therapeutic drug monitoring of voriconazole in pediatric patients[J].Chin J Mod Appl Pharm(中国现代应用药学),2021,38(12):1529-1536.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1403次   下载 760 本文二维码信息
码上扫一扫!
分享到: 微信 更多
儿童患者伏立康唑治疗药物监测研究进展
田雪珂, 张绮雯, 贾萌萌, 杨晶, 张晓坚
郑州大学第一附属医院, 郑州 450052
摘要:
伏立康唑在成人体内呈现非线性药动学特征,主要在肝脏中代谢,受基因多态性和药物相互作用的影响,个体间及个体内差异较大。因此,治疗药物监测在伏立康唑临床应用中发挥重要作用。相比成人,儿童患者的药动学更加复杂,目前针对儿童群体的研究数据相对较少,对于儿童目标浓度范围及剂量的调整策略尚存在争议,故该群体使用伏立康唑存在较大风险。本文分别从治疗药物监测必要性、监测策略、剂量调整策略共3个方面分析了儿童患者中伏立康唑治疗药物监测研究进展,以期为儿童患者临床抗真菌感染治疗提供参考。
关键词:  伏立康唑|儿童|药动学|治疗药物监测|基因多态性
DOI:10.13748/j.cnki.issn1007-7693.2021.12.022
分类号:R969.3
基金项目:
Research Progress of therapeutic drug monitoring of voriconazole in pediatric patients
TIAN Xueke, ZHANG Qiwen, JIA Mengmeng, YANG Jing, ZHANG Xiaojian
The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
Abstract:
Voriconazole has a nonlinear pharmacokinetic profile with wide inter- and intra-individual varieties in adults, polymorphisms and drug-drug interactions complicate treatment since it is extensively metabolized by the liver. Therefore, therapeutic drug monitoring plays an important role in clinical practice of voriconazole. Compared with that in adults, the pharmacokinetic behavior of voriconazole in pediatric patients is more complicated. However, the data are limited so the target range of voriconazole concentration and recommendations for dose adjustments of voriconazole have not been well described for a large cohort of pediatric patients, which indicates that these patients might be at higher risk. This article analyzes the research progress of voriconazole therapeutic drug monitoring in pediatric patients from three aspects:the necessity of therapeutic drug monitoring, monitoring strategy, and dose adjustment strategy, in order to provide a reference for clinical antifungal infection treatment in pediatric patients.
Key words:  voriconazole|pediatric|pharmacokinetics|therapeutic drug monitoring|gene polymorphism
扫一扫关注本刊微信